Literature DB >> 11522885

Light chain deposit disease: a frequent cause of diagnostic difficulty.

C L Hall1, D S Peat.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11522885     DOI： 10.1093/ndt/16.9.1939

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Complete remission of lambda light chain myeloma presenting with acute renal failure following treatment with bortezomib and steroids.

Authors:  M Pavan; K A Ashwini; R Ravi; L H Suratkal
Journal:  Indian J Nephrol       Date:  2010-04

2.  Light chain deposition disease; there are reasons for confusion.

Authors:  Mohammad-Reza Ardalan
Journal:  J Renal Inj Prev       Date:  2013-10-10

3.  Light-Chain Deposition Disease with Prominent Hepatic Involvement.

Authors:  Ana Cristino; Carmen Pais; Renata Silva; Paulo Carrola
Journal:  Eur J Case Rep Intern Med       Date:  2017-04-27

4.  Cyclophosphamide, bortezomib and dexamethasone (CyBorD): a promising regimen for renal light chain deposit disease.

Authors:  Arunima Dutta; Kavitha Kesari; Trevor Singh
Journal:  BMJ Case Rep       Date:  2020-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.